Low-Dose Fludarabine and Cyclophosphamide With Rituximab in the First-Line Treatment of Elderly/Comorbid Patients With CLL/SLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low-Dose Fludarabine and Cyclophosphamide Combined With Rituximab in the First-Line Treatment of Elderly/Comorbid Patients With Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma (CLL/SLL): Long-Term Results of Project Q-Lite by the Czech CLL Study Group
Br. J. Haematol 2021 Feb 22;[EPub Ahead of Print], L Smolej, Y Brychtová, E Cmunt, M Doubek, M Špaček, D Belada, M Šimkovič, L Stejskal, I Zygulová, R Urbanová, M Brejcha, J Zuchnická, H Móciková, T KozákFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.